Pronova Biopharma ASA Company Profile - Aug 27, 2011 by WrightReports

VIEWS: 20 PAGES: 9

More Info
									Company Fundamentals\Company Profile

   A Wright Investors' Service Research Report:

   Pronova Biopharma ASA
                                                                                         440 Wheelers Farms Road
                                                                                         Milford, CT 06461 U.S.A.


  COMPANY PROFILE
  Figures in Norwegian Kroner

                                 Wright Quality Rating:CCNN                                 Key Data

   Pronova BioPharma ASA is a Norway-based biotechnology company. The Company is            Ticker:
   engaged in the research, development and manufacture of marine-originated omega-         PRON
   3 derived pharmaceutical products. Its first commercialized product using the
   Company's active pharmaceutical ingredient is the omega-3 derived prescription           2010 Sales:
   drug, Omacor/Lovaza. Omacor/Lovaza has been approved in the United States and
                                                                                            1,643,747,000
   certain European and Asian markets, and is prescribed as an adjunct to diet for the
   treatment of elevated levels of triglycerides in humans. The Company's products
   have also been approved in certain European and Asian markets for the secondary          Major Industry:
   prevention of post-myocardial infarction. Its products are distributed in 46 countries   Drugs, Cosmetics & Health
   through a network of regional distribution partners. Pronova BioPharma ASA has two       Care
   subsidiaries, Pronova BioPharma Norge AS and Pronova BioPharma Danmark A/S.
                         Stock Chart                                  Officers              Sub Industry:
                                                                     Chairman               Ethical Drug Manufacturers
                                                                   Gert W. Munthe
                                                                                            Country:
                                                                  Vice Chairman             Norway
                                                              Rikke Tobiasson Reinemo
                                                                                            Currency:
                                                              Chief Executive Officer       Norwegian Kroner
                                                                    Morten Jurs
                                                                                            Fiscal Year Ends:
                                                               Chief Financial Officer
                                                                                            December
                                                                   Synne H. Roine

                                                                                            Employees
                                                                                            297

                                                                                            Exchanges:
                                                                                            OSA

                                                                    
								
To top